Meibomianitis is an inflammatory disease of the meibomian glands located in the upper and lower eyelids, which are responsible for the secretion of oil necessary for the stability of the tear film. The disease can manifest itself both acutely and chronically, accompanied by symptoms such as pain, redness of the eyelids, itching, swelling and discharge from the eyes. Meibomianitis can lead to serious complications, including keratitis, conjunctivitis and other pathologies affecting vision. This disease requires a professional approach to diagnosis and treatment to avoid possible long-term consequences for the patient's health.
History of the disease and interesting historical facts
The history of meibomianitis goes back centuries. The first descriptions of the meibomian glands were made in the 19th century, when the English ophthalmologist John Meibom noted their role in the formation of the tear film. In medical texts of various eras, meibomianitis was often confused with other forms of inflammatory diseases of the eyelids. It is interesting to note that at the beginning of the 20th century, meibomianitis was not always recognized as an independent disease, and doctors were more inclined to believe that it was a symptom of a general inflammatory process. Over time, the study of the histology of the meibomian glands and their physiology led to meibomianitis becoming a separately studied condition, which contributed to the development of more effective methods for its diagnosis and treatment.
Epidemiology
According to statistics, meibomianitis occurs in 15-35% patients who seek ophthalmologist's attention with complaints of eye diseases. Epidemiological studies show that the incidence of meibomianitis increases with age, especially among people over 50 years of age, which may be associated with age-related changes in the structure of the meibomian glands and lacrimal apparatus. In addition, women are prone to increased incidence of meibomianitis, which may be associated with hormonal changes. In a number of regions of the world, the incidence of meibomianitis increases among the population with certain professions associated with high visual loads or unfavorable working conditions.
Genetic predisposition to this disease
The study of genetic predisposition to meibomianitis has identified several key genes involved in the regulation of meibomian gland function. The KRT17 gene, which is responsible for the stability of cell membranes, is in some cases associated with increased sensitivity to inflammation. Researchers are also studying mutations in genes associated with the production of tears and their oils, which can lead to a deficiency in secretion or a change in the quality of the secretion. In addition, attention is paid to gene mutations associated with autoimmune processes, which can aggravate the course of meibomianitis.
Risk factors for the development of this disease
There are a number of risk factors that contribute to the development of meibomianitis, which can be classified into physical and chemical:
- Age-related changes: in older people, there is a decrease in the function of the meibomian glands.
- Professional factors: workers who are constantly in front of PC screens are much more likely to suffer from meibomianitis.
- Hormonal changes: In women during menopause, changes in the composition and quantity of meibomian gland secretions are observed.
- Allergic reactions: may cause inflammation of the eyelids and lead to the development of meibomianitis.
- Deficiency of fatty acids in the diet: Deficiency of Omega-3 and Omega-6 can contribute to the development of the disease.
- Smoking and exposure to toxic chemicals: negatively impact eye health.
Diagnosis of this disease
Diagnosis of meibomianitis includes several stages that allow for the correct diagnosis and adequate treatment:
- Main symptoms: patients most often complain of redness and itching of the eyelids, painful sensations when blinking and discharge from the eyes.
- Laboratory tests: determination of the quality and quantity of meibomian gland secretions, collection of smears for microbiological analysis.
- Radiological examinations: use of ultrasound to evaluate the condition of the meibomian glands.
- Other diagnostics: use of Tear Clarifying Therapy to assess the functioning of the lacrimal glands.
- Differential diagnosis: Other causes of eye inflammation such as conjunctivitis, blepharitis or keratitis must be excluded.
Treatment
Treatment of meibomianitis may include both conservative and surgical approaches:
- General treatment: eyelid care and warm compresses to improve oil secretion are recommended.
- Pharmacological treatment: administration of anti-inflammatory and antibacterial drugs such as non-steroidal anti-inflammatory drugs.
- Surgical treatment: In severe cases, drainage of the abscess or plastic surgery of the meibomian glands may be required.
- Other treatments include using artificial tears to improve comfort and reduce symptoms.
List of medications used to treat this disease
Some of the most commonly used medications to treat meibomianitis include:
- Tetracycline ointment.
- Dexamethasone drops.
- Drops with hyaluronic acid.
- Anti-inflammatory drugs for local use.
- Tear substitutes to maintain the required level of moisture.
Disease monitoring
Monitoring a patient with meibomianitis involves monitoring symptoms and response to treatment. Standard monitoring steps include:
- Regular examinations by an ophthalmologist to assess the condition of the meibomian glands.
- Evaluation of the dynamics of symptoms and the quality of the tear film.
- Assessing the possibility of complications, such as the development of keratitis.
The prognosis with adequate and timely treatment can be considered favorable. However, some patients may develop a chronic form of the disease, which requires additional monitoring.
Age-related features of the disease
Meibomianitis can present differently in different age groups:
- In children: meibomianitis often occurs in a mild form, but requires consideration of the peculiarities of their anatomical structure.
- In young people: it often manifests itself in acute forms associated with the active use of gadgets.
- In older people: there is a marked decrease in the function of the meibomian glands, which leads to more frequent relapses of the disease.
Questions and Answers
- What are the main symptoms of meibomianitis? The main symptoms are redness and swelling of the eyelids, itching, discharge from the eyes and pain when blinking.
- What factors contribute to the development of meibomianitis? Risk factors include age, hormonal changes, professional activity, allergies and bad habits.
- How to diagnose meibomianitis? Diagnosis includes examination by an ophthalmologist, laboratory tests of secretions and differential diagnosis with other diseases.
- How is meibomianitis treated? Treatment may include heat compresses, the use of anti-inflammatory drugs, and in severe cases, surgery.
- What is the prognosis for meibomianitis? With timely and adequate treatment, the prognosis is favorable, but the disease may be recurrent.
